106+ Free Reválida Médica UBA Practice Questions

Prepare for the Examen General de Competencias Profesionales para Reválida de Título Médico Extranjero (Universidad de Buenos Aires) exam with instant access — no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

45% Pass Rate

106+ Questions

100% Free

Loading practice questions...

2026 Statistics

Key Facts: Reválida Médica UBA Exam

100

Total MCQs

UBA Facultad de Medicina format

240 min

Exam Duration

4 hours continuous testing

60%

Passing Threshold

Grade >= 4/10 on Argentine academic scale

45%

Average Pass Rate

UBA Foreign Degree Evaluation Committee

30%

Internal Medicine Weight

Official examination blueprint

20%

Surgery & Trauma Weight

Official examination blueprint

20%

Pediatrics & Neonatology Weight

Official examination blueprint

15% / 15%

OB/GYN & Health Legislation

Official examination blueprint

The UBA Medical Degree Revalidation Exam is a 100-question, 4-hour written multiple-choice test administered at the UBA Facultad de Medicina in Buenos Aires. The blueprint is weighted Internal Medicine 30%, General Surgery & Trauma 20%, Pediatrics & Neonatology 20%, Obstetrics & Gynecology 15%, and Legal Medicine & Argentine Health Legislation 15%. The passing threshold is 60% (grade 4/10). Passing this rigorous exam is the definitive academic requirement for foreign physicians to practice medicine and enter residency programs in Argentina.

Sample Reválida Médica UBA Practice Questions

Try these sample questions to test your Reválida Médica UBA exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 106+ question experience with AI tutoring.

1A 58-year-old male presents to a community hospital without a catheterization laboratory with 90 minutes of crushing substernal chest pain radiating to his left arm. The initial 12-lead ECG demonstrates 3 mm ST-segment elevation in leads V1 through V4. The estimated transfer time to the nearest percutaneous coronary intervention (PCI) center is 150 minutes. Which reperfusion strategy is most appropriate according to clinical practice guidelines?

A.Immediate administration of IV fibrinolytic therapy within 30 minutes of medical contact

B.Immediate transfer for primary percutaneous coronary intervention (PCI) despite the expected delay

C.Conservative medical management with dual antiplatelet therapy and heparin, deferring coronary angiography

D.Urgent coronary artery bypass graft (CABG) surgery without prior angiography

Explanation: According to SAC (Sociedad Argentina de Cardiología) and international STEMI guidelines, when primary PCI cannot be performed within 120 minutes of first medical contact, immediate fibrinolytic therapy (e.g., tenecteplase, alteplase) should be administered within 30 minutes (door-to-needle time) in eligible patients presenting within 12 hours of symptom onset. Following fibrinolysis, the patient should be transferred to a PCI-capable center for routine pharmacoinvasive angiography within 2-24 hours.

2A 64-year-old male with a history of anterior myocardial infarction has heart failure with reduced ejection fraction (LVEF 28%). He is currently receiving enalapril 10 mg twice daily and bisoprolol 5 mg daily. He remains in NYHA functional class II with an eGFR of 52 mL/min/1.73 m² and serum potassium of 4.3 mEq/L. Which pharmacological combination represents the most guideline-directed next step to reduce mortality?

A.Add digoxin and increase the dose of loop diuretics

B.Add a mineralocorticoid receptor antagonist (spironolactone) and an SGLT2 inhibitor (dapagliflozin or empagliflozin)

C.Discontinue bisoprolol and start diltiazem for rate control

D.Add oral hydralazine and isosorbide dinitrate while discontinuing enalapril

Explanation: Guideline-directed medical therapy (GDMT) for HFrEF (LVEF <= 40%) is based on four foundational pillars that significantly reduce cardiovascular mortality and hospitalization: an ARNI/ACEi/ARB, an evidence-based beta-blocker, a mineralocorticoid receptor antagonist (MRA such as spironolactone), and an SGLT2 inhibitor (dapagliflozin or empagliflozin). With a normal potassium and preserved renal function, adding spironolactone and an SGLT2i fulfills optimal foundational therapy.

3A 52-year-old female presents for a routine check-up. Her seated blood pressure is 164/98 mmHg on two separate office visits. She has no history of diabetes, cardiovascular disease, or target organ damage. According to the Argentine Consensus on Arterial Hypertension (SAC/FAC/SAHA), what is the recommended initial management strategy?

A.Initiate monotherapy with a low-dose loop diuretic and re-evaluate in 6 months

B.Recommend lifestyle modifications alone for 6 months before considering any pharmacotherapy

C.Initiate combination therapy with two first-line antihypertensive agents from different classes (e.g., ACEi or ARB plus DHP calcium channel blocker or thiazide-like diuretic)

D.Initiate dual therapy with an ACE inhibitor combined with an Angiotensin Receptor Blocker (ARB)

Explanation: Per Argentine consensus guidelines (SAC/FAC/SAHA), patients with Stage 2 hypertension (BP >= 160/100 mmHg or >= 20/10 mmHg above target) should initiate therapy with a single-pill fixed-dose combination of two first-line agents (an ACEi or ARB combined with a dihydropyridine calcium channel blocker or a thiazide/thiazide-like diuretic) alongside lifestyle modifications to rapidly achieve blood pressure control (<130/80 mmHg).

4A 68-year-old male with a history of hypertension, type 2 diabetes mellitus, and a transient ischemic attack (TIA) two years ago is diagnosed with new-onset non-valvular atrial fibrillation. Transthoracic echocardiography reveals normal valvular structure and a left ventricular ejection fraction of 55%. What is the most appropriate antithrombotic strategy for stroke prevention?

A.Aspirin 100 mg daily plus clopidogrel 75 mg daily

B.No antithrombotic therapy is required because the patient is currently in sinus rhythm

C.Aspirin 100 mg daily monotherapy

D.Oral anticoagulation with a Direct Oral Anticoagulant (DOAC) such as apixaban, rivaroxaban, or dabigatran

Explanation: The patient has a CHA2DS2-VASc score of 5 (Age 65-74 = 1, Hypertension = 1, Diabetes = 1, prior Stroke/TIA = 2). With a score >= 2 in men, oral anticoagulation is strongly indicated. Direct oral anticoagulants (DOACs) are preferred over vitamin K antagonists (such as acenocoumarol or warfarin) in non-valvular AF due to superior efficacy, lower intracranial hemorrhage risk, and no requirement for routine INR monitoring.

5A 72-year-old female presents to the emergency department with a 3-day history of productive cough with rust-colored sputum, right pleuritic chest pain, and progressive dyspnea. Physical examination reveals confusion (new onset), respiratory rate of 32 breaths/min, blood pressure of 86/54 mmHg, and crackles with bronchial breath sounds over the right lower hemithorax. Laboratory testing shows blood urea nitrogen (BUN) of 28 mg/dL (urea > 7 mmol/L). According to the CURB-65 score, what is her risk stratification and appropriate setting of care?

A.CURB-65 score 4: Severe risk; hospital admission, preferably in an intensive care or intermediate care unit, with parenteral antibiotic therapy

B.CURB-65 score 2: Intermediate risk; short outpatient observation or home treatment with oral levofloxacin

C.CURB-65 score 1: Low risk; suitable for outpatient management with oral amoxicillin

D.CURB-65 score 0: Low risk; symptomatic outpatient treatment with antitussives

Explanation: The patient fulfills 4 criteria of the CURB-65 score: Confusion (+1), Urea > 7 mmol/L (+1), Respiratory rate >= 30/min (+1), and Blood pressure < 90/60 mmHg (+1), plus Age >= 65 (+1), yielding a score of 4 or 5. A CURB-65 score of 3 to 5 indicates severe community-acquired pneumonia (NAC) with high 30-day mortality (15-40%), warranting urgent inpatient admission (ICU/step-down unit) and IV combination antimicrobial therapy (e.g., ceftriaxone plus macrolide or respiratory fluoroquinolone).

6A 66-year-old male with severe chronic obstructive pulmonary disease (COPD, GOLD Stage 3) presents with 4 days of increased shortness of breath, increased sputum volume, and frank change of sputum color from clear to purulent green. He has no fever or hemodynamic instability. Room air oxygen saturation is 89% (baseline 92%). Which therapeutic combination is indicated for this acute exacerbation according to GOLD/AAM consensus?

A.Oral theophylline, high-dose intravenous methylprednisolone for 21 days, and no antibiotics

B.Inhaled short-acting bronchodilators (SABA + SAMA), a 5-day course of systemic corticosteroids (prednisone 40 mg/day), and oral antibiotic therapy

C.Inhaled corticosteroid monotherapy without bronchodilators or antibiotics

D.Immediate endotracheal intubation, mechanical ventilation, and long-term prophylactic macrolide therapy

Explanation: This patient presents with a Type 1 Anthonisen exacerbation of COPD (all three cardinal symptoms: increased dyspnea, increased sputum volume, and sputum purulence). Evidence-based management comprises intensified short-acting bronchodilators (inhaled beta-2 agonist plus anticholinergic, e.g., salbutamol + ipratropium), a short course of oral systemic corticosteroids (prednisone 40 mg daily for 5 days), and oral antibiotics (e.g., amoxicillin-clavulanate or azithromycin for 5-7 days) to reduce treatment failure and relapse.

7A 28-year-old female with persistent asthma reports daytime symptoms 4 days per week, night-time awakenings with cough once weekly, and using her short-acting beta-2 agonist (SABA) inhaler 4 times a week. Her FEV1 is 78% of predicted. According to GINA guidelines (Global Initiative for Asthma, Track 1), what is the preferred controller and reliever regimen for this patient?

A.SABA as-needed alone without any controller medication

B.Daily high-dose oral prednisone monotherapy without inhalers

C.Low-dose inhaled corticosteroid (ICS) combined with formoterol taken as both daily maintenance and as-needed reliever (MART / SMART strategy)

D.Daily oral montelukast with SABA as-needed only

Explanation: Under GINA guidelines (Track 1 preferred strategy), the combination of a low-dose inhaled corticosteroid (ICS) and formoterol (a rapid-acting, long-acting beta-2 agonist) as both daily maintenance and as-needed reliever therapy (Maintenance and Reliever Therapy - MART) is preferred. This strategy significantly reduces severe exacerbation rates compared to SABA-only reliever regimens by ensuring anti-inflammatory coverage whenever bronchodilation is required.

8A 34-year-old male with no prior history of tuberculosis is diagnosed with smear-positive pulmonary tuberculosis (Ziehl-Neelsen sputum smear 3+ acid-fast bacilli). He is HIV-negative and has normal baseline liver function. According to the Argentine National Tuberculosis Control Program (Programa Nacional de Control de la Tuberculosis), what is the standard first-line treatment regimen?

A.6 months of daily Isoniazid and Rifampicin monotherapy

B.12 months of daily Bedaquiline, Linezolid, and Levofloxacin

C.2 months of Streptomycin, Ciprofloxacin, and Ethambutol, followed by 7 months of Isoniazid

D.2 months of daily Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol (2HRZE), followed by 4 months of daily Isoniazid and Rifampicin (4HR)

Explanation: The standard first-line treatment for drug-susceptible pulmonary tuberculosis under Argentine national guidelines and WHO standards consists of a 6-month regimen: an initial intensive phase of 2 months with 4 drugs—Isoniazid (H), Rifampicin (R), Pyrazinamide (Z), and Ethambutol (E) (2HRZE)—followed by a continuation phase of 4 months with 2 drugs—Isoniazid and Rifampicin (4HR), administered under Directly Observed Therapy (DOTS/TAES).

9A 54-year-old male with alcoholic cirrhosis presents with marked abdominal distension. Diagnostic paracentesis yields clear yellow ascitic fluid. Laboratory results show: serum albumin 3.2 g/dL, ascitic fluid albumin 1.4 g/dL, and total ascitic protein 1.1 g/dL. What does the Serum-Ascites Albumin Gradient (SAAG) indicate, and what is the first-line medical management?

A.SAAG 1.8 g/dL (>= 1.1 g/dL), indicating portal hypertension; treat with sodium restriction and combination diuretics (spironolactone plus furosemide)

B.SAAG 1.8 g/dL (>= 1.1 g/dL), indicating non-portal hypertensive ascites; treat with systemic corticosteroids

C.SAAG 0.8 g/dL (< 1.1 g/dL), indicating peritoneal carcinomatosis; treat with systemic chemotherapy

D.SAAG 0.4 g/dL (< 1.1 g/dL), indicating nephrotic syndrome; treat with ACE inhibitors

Explanation: SAAG is calculated as Serum Albumin (3.2 g/dL) minus Ascitic Albumin (1.4 g/dL) = 1.8 g/dL. A SAAG >= 1.1 g/dL indicates portal hypertension with ~97% diagnostic accuracy (most commonly cirrhosis, congestive heart failure, or Budd-Chiari syndrome). First-line medical therapy for cirrhotic ascites consists of dietary sodium restriction (<2 g/day) and combined oral diuretic therapy with spironolactone (100 mg/day) and furosemide (40 mg/day), titrated maintaining the 100:40 mg ratio to preserve normokalemia.

10A 59-year-old female with cirrhosis and ascites presents with low-grade fever (37.9°C), mild diffuse abdominal tenderness, and worsened encephalopathy. Diagnostic paracentesis reveals ascitic fluid with a polymorphonuclear (PMN) neutrophil count of 450 cells/mm³. Sputum and urine cultures are negative. What is the diagnosis and the most appropriate immediate medical intervention?

A.Secondary bacterial peritonitis; emergency exploratory laparotomy

B.Spontaneous bacterial peritonitis (SBP / PBP); initiate intravenous third-generation cephalosporin (e.g., cefotaxime or ceftriaxone) plus intravenous albumin infusion

C.Sterile ascitic decompensation; increase outpatient oral spironolactone dose

D.Tuberculous peritonitis; initiate 4-drug antitubercular therapy

Explanation: An ascitic fluid PMN count >= 250 cells/mm³ is diagnostic of spontaneous bacterial peritonitis (SBP / peritonitis bacteriana espontánea), even before culture results are available. Standard treatment is an empirical IV third-generation cephalosporin (e.g., cefotaxime 2g q8h or ceftriaxone 2g q24h). In addition, intravenous albumin (1.5 g/kg within 6 hours of diagnosis, followed by 1.0 g/kg on day 3) is indicated to reduce the incidence of type 1 hepatorenal syndrome and significantly improve survival.

About the Reválida Médica UBA Exam

The Examen General de Competencias Profesionales para Reválida de Título Médico Extranjero is the official qualifying academic examination administered by the Facultad de Medicina of the Universidad de Buenos Aires (UBA), Argentina's premier public university. Under Ley de Educación Superior 24.521, foreign-trained medical graduates whose degrees are not covered by automatic bilateral ministerial recognition agreements must undergo academic revalidation to obtain an Argentine medical degree equivalent. The examination evaluates core clinical competencies across five principal domains: Internal Medicine (30%), General Surgery & Trauma (20%), Pediatrics & Neonatology (20%), Obstetrics & Gynecology (15%), and Legal Medicine, Bioethics & Argentine Health Legislation (15%). The test comprises 100 multiple-choice questions administered in a single 4-hour session. A minimum score of 60% (or grade 4 on the Argentine 1-10 academic scale) is required to pass, enabling candidates to proceed toward formal degree conferral and national medical licensing (Matrícula Nacional) issued by the Argentine Ministry of Health. Language and format note: UBA's Examen General de Competencia Profesional is written and sat in Spanish, and non-Spanish-speaking applicants must additionally pass a Spanish-language examination plus prior checks in Argentine History, Geography and Civics. These practice questions are an English-language multiple-choice study adaptation of the exam's published prevalent topics — not an official translation, not endorsed by the Universidad de Buenos Aires, and not a substitute for the Spanish-language and civics components of the revalidation process.

Questions

100 scored questions

Time Limit

240 minutes (4 hours)

Passing Score

60% correct WITHIN EACH orientation, not 60 out of 100 overall. UBA's Examen General de Competencia Profesional is a written paper of 100 questions separated by specialty; a candidate is APROBADO only when they reach 60% in every orientation, and scoring under 60% in one or more orientations is DESAPROBADO regardless of the total score, requiring a re-sit at the next scheduled date.

Exam Fee

UBA administrative revalidation processing fee (Universidad de Buenos Aires — Facultad de Medicina / Dirección de Reválidas)

Reválida Médica UBA Exam Content Outline

30%

Internal Medicine (Clínica Médica)

Comprehensive adult clinical pathology: Cardiology (coronary artery disease, acute STEMI reperfusion windows, NSTEMI management, HFrEF four-pillar GDMT with ARNI/BB/MRA/SGLT2i, Argentine SAC/SAHA hypertension consensus, atrial fibrillation CHA2DS2-VASc and DOAC anticoagulation), Pulmonology (CAP/NAC CURB-65 stratification, COPD Anthonisen criteria and acute therapy, GINA asthma management with SMART/MART ICS-formoterol, Argentine National Tuberculosis Control Program 2HRZE/4HR regimen), Gastroenterology & Hepatology (cirrhosis complications, ascites SAAG >= 1.1 g/dL, spontaneous bacterial peritonitis PMN >= 250 with cefotaxime and IV albumin, acute variceal bleeding vasoactive drugs and band ligation, Revised Atlanta acute pancreatitis severity), Nephrology (KDIGO AKI staging and FeNa differentiation, CKD staging and anemia iron repletion, severe hyperkalemia calcium gluconate membrane stabilization, symptomatic hyponatremia 3% NaCl correction limits, high anion gap metabolic acidosis and Winter's formula), Infectious Diseases (Chagas disease indeterminate vs cardiac forms, RBBB+LAFB ECG, benznidazole therapy, Dengue warning signs and fluid resuscitation, Andes Hantavirus pulmonary syndrome, HIV opportunistic infection prophylaxis with TMP-SMX), Endocrinology (DKA vs HHS fluid and insulin protocols, T2D with ASCVD/HF SGLT2i/GLP-1RA, primary hypothyroidism levothyroxine), and Neurology (ischemic stroke 4.5h IV rtPA window, giant cell arteritis high-dose steroids, acute bacterial meningitis empiric ceftriaxone + dexamethasone).

20%

General Surgery and Trauma (Cirugía General y Trauma)

Acute surgical abdomen (Alvarado score for acute appendicitis, Tokyo Guidelines TG18/TG24 for acute cholecystitis and early cholecystectomy <72h, perforated peptic ulcer pneumoperitoneum and Graham patch, Hinchey classification of diverticulitis and percutaneous drainage, adhesive small bowel obstruction, sigmoid volvulus coffee bean sign and endoscopic detorsion), Trauma management and ATLS protocols (ABCDE primary survey, tension pneumothorax immediate needle decompression 5th ICS anterior axillary line and chest tube thoracostomy, hemorrhagic shock Class I-IV and 1:1:1 balanced resuscitation with tranexamic acid, eFAST indications in unstable trauma, lethal triad of hypothermia-acidosis-coagulopathy and damage control surgery, cardiac tamponade Beck's triad), Burn management (Wallace Rule of Nines, Parkland formula fluid calculation and urine output titration, inhalation injury early intubation), Abdominal wall hernias (indirect vs direct inguinal, crural/femoral hernia high strangulation risk, strangulated hernia emergency surgery), and Surgical site infection prevention (CDC wound classes I-IV, preoperative cefazolin within 60 min).

20%

Pediatrics and Neonatology (Pediatría y Neonatología)

Normal growth and developmental milestones (weight triples at 1 year, length doubles at 4 years, 9-month pincer grasp and stranger anxiety), Infant nutrition and Sociedad Argentina de Pediatría (SAP) guidelines (exclusive breastfeeding for 6 months, Vitamin D 400 IU/day, iron supplementation 1 mg/kg/day at 4 months), Acute respiratory infections (RSV bronchiolitis supportive care and avoidance of routine bronchodilators, croup Westley score and single-dose dexamethasone, pediatric community-acquired pneumonia amoxicillin 80-100 mg/kg/day), Acute gastroenteritis and dehydration (WHO/SAP Plans A, B [ORS 50-100 mL/kg over 4h], and C [IV crystalloids 20 mL/kg bolus]), Common pediatric exanthems (measles Koplik spots, rubella lymphadenopathy, scarlet fever Pastia lines and strawberry tongue, erythema infectiosum slapped cheek, roseola infantum fever drop by crisis, varicella polymorphic dewdrop vesicles), Neonatal resuscitation (NRP algorithm, PPV with room air 21% O2 for HR <100/apnea, APGAR scoring, pathologic jaundice in first 24h due to isoimmunization and phototherapy), and the Argentine Calendario Nacional de Vacunación (at birth BCG + HepB; 2-4-6 months Quíntuple + IPV + Neumo13 + Rotavirus; 12 months SRP + Neumo booster + HepA; 15 months Varicela + MenACWY booster; 11 years dTpa + MenACWY + updated single-dose HPV).

15%

Obstetrics and Gynecology (Tocoginecología)

Routine prenatal care and national mandatory screening (first visit CBC, Rh/Coombs, glucose, VDRL, HIV, Chagas HAI/ELISA, HBsAg, Toxoplasmosis, urine culture; preconception folic acid 0.4 mg vs 4-5 mg high risk; Anti-D gamma globulin at 28w and postpartum), Hypertensive disorders of pregnancy (gestational hypertension, preeclampsia with severe features, eclampsia seizure management with Zuspan magnesium sulfate protocol, antihypertensive selection with labetalol/nifedipine, calcium gluconate antidote), Obstetric hemorrhages (first-trimester ectopic pregnancy methotrexate criteria vs laparoscopy, threatened vs incomplete abortion; third-trimester placenta previa painless bleeding vs placental abruption painful woody uterus), Gestational diabetes mellitus (Argentine Diabetes Society / SAD criteria: fasting glucose >= 100 mg/dL x2 or 75g OGTT 2h >= 140 mg/dL at 24-28w), Normal labor and postpartum hemorrhage (AMTSL with prophylactic oxytocin 10 IU, 4 T's etiology, uterine atony management and carboprost contraindication in asthma / methylergonovine in hypertension), Cervical cancer screening (Argentine National Program: HPV-DNA molecular testing every 5y for ages 30-64; PAP cytology every 3y for ages 25-29), and Contraception (copper IUD / LNG-IUS safety in nulliparous, emergency contraception levonorgestrel 1.5 mg within 72-120h, menopausal hormone therapy progestogen requirement).

15%

Legal Medicine, Bioethics and Health Legislation (Medicina Legal, Bioética y Legislación Sanitaria)

Medical death certification (DEIS / WHO rules for Certificado Médico de Defunción: Part I immediate, intermediate, and underlying basic cause; strict prohibition of non-specific terms like paro cardiorrespiratorio or falla multiorgánica; mandatory reporting of violent, accidental, or suspicious deaths to judicial authorities for forensic autopsy), Forensic medicine (thanatology, early signs of death, Nysten's law of rigor mortis, fixed livor mortis at 8-12h, mechanical asphyxias: hanging vs strangulation furrows), Patient rights and medical records under Ley Nacional 26.529 (patient is exclusive owner/titular of medical records, 48-hour mandatory delivery rule, 10-year preservation, informed consent in writing for surgery/invasive procedures), Professional secrecy (Art. 156 Código Penal and justa causa exceptions: Ley 15.465 notifiable diseases, abuse reporting, self-defense), Ley Nacional 17.132 (medical practice legal framework, prohibition of secret codes, delegating medical acts, or promising cures), Ley Nacional 26.657 (Mental Health Act: involuntary admission as last resort requiring interdisciplinary assessment, cierto e inminente riesgo, 48h judicial notice), Ley Nacional 27.610 (IVE/ILE: voluntary termination up to week 14 inclusive, maximum 10 calendar days, conscientious objection rules and mandatory referral), and Medical malpractice liability (imprudencia, impericia, negligencia, inobservancia de deberes).

How to Pass the Reválida Médica UBA Exam

What You Need to Know

Passing score: 60% correct WITHIN EACH orientation, not 60 out of 100 overall. UBA's Examen General de Competencia Profesional is a written paper of 100 questions separated by specialty; a candidate is APROBADO only when they reach 60% in every orientation, and scoring under 60% in one or more orientations is DESAPROBADO regardless of the total score, requiring a re-sit at the next scheduled date.
Exam length: 100 questions
Time limit: 240 minutes (4 hours)
Exam fee: UBA administrative revalidation processing fee

Keys to Passing

Work through all 106 available questions
Review every answer and explanation
Track weak areas and revisit them
Use our AI tutor for tough concepts

Reválida Médica UBA Study Tips from Top Performers

1Dedicate 30% of your study schedule to Internal Medicine, focusing heavily on cardiology (ACS reperfusion windows, HFrEF 4 pillars), pulmonology (CAP, TB 2HRZE/4HR), and regional infectious diseases (Chagas, Dengue, Hantavirus)

2Master the Argentine Calendario Nacional de Vacunación, paying close attention to newborn vaccines (BCG, HepB), 2-month infant vaccines (Quíntuple, IPV, Neumo13, Rotavirus), and the updated 11-year single-dose HPV schedule

3Memorize the precise rules for filling out the Certificado Médico de Defunción under DEIS/WHO standards — never write 'paro cardiorrespiratorio' as the basic cause, and know when judicial reporting is legally mandated

4Study Argentine Health Legislation thoroughly: Ley 26.529 (patient is owner of medical records; 48-hour delivery rule), Ley 26.657 (involuntary admission criteria: cierto e inminente riesgo), and Ley 27.610 (IVE up to week 14 inclusive; 10-day limit)

5Learn the legal distinctions of medical malpractice under Argentine law: Imprudencia (rashness), Impericia (lack of skill/knowledge), Negligencia (omission of duty), and Inobservancia de deberes

6Review ATLS primary survey protocols: immediate needle decompression at the 5th intercostal space anterior axillary line for tension pneumothorax, and 1:1:1 balanced resuscitation with tranexamic acid for hemorrhagic shock

7Understand the diagnostic thresholds for Gestational Diabetes according to the Sociedad Argentina de Diabetes (SAD): fasting glucose >= 100 mg/dL confirmed on two occasions or 2-hour 75g OGTT >= 140 mg/dL at 24-28 weeks

8Know the Tokyo Guidelines (TG18/TG24) for acute cholecystitis (early laparoscopic cholecystectomy within 72 hours) and Hinchey classification for acute diverticulitis (percutaneous drainage for Hinchey II abscesses)

9Familiarize yourself with the Zuspan Magnesium Sulfate protocol (4g IV loading dose, 1g/h maintenance) for severe preeclampsia/eclampsia and the administration of IV 10% Calcium Gluconate for toxicity

10Practice timed 100-question simulations in 240 minutes to build pacing, answering at a target speed of 2.0 to 2.4 minutes per clinical vignette

Frequently Asked Questions

What is the Reválida de Título Médico at UBA?

The Reválida de Título Médico is the official academic degree revalidation process conducted by the Universidad de Buenos Aires (UBA) Facultad de Medicina under Ley de Educación Superior 24.521. It allows foreign-trained physicians from countries without automatic ministerial convalidation treaties to obtain full academic equivalence of their medical degree (Título de Médico), qualifying them for national licensure and residency examinations in Argentina.

What is the format, duration, and passing score of the UBA revalidation exam?

The general written qualifying examination consists of 100 multiple-choice questions (MCQs) with 4 options and a single correct answer. Candidates are allotted 240 minutes (4 hours) to complete the test. The minimum passing score is 60% (60 correct answers out of 100), which corresponds to a passing grade of 4 on the Argentine 1-to-10 academic grading scale.

What subjects and topics are covered in the exam?

The examination blueprint covers five major clinical areas: Internal Medicine (30%), General Surgery and Trauma (20%), Pediatrics and Neonatology (20%), Obstetrics and Gynecology (15%), and Legal Medicine, Bioethics and Argentine Health Legislation (15%). Questions emphasize clinical decision-making, emergency management, and Argentine national practice guidelines (SAC, SAP, SADI, SAD) and statutory laws (Leyes 17.132, 26.529, 26.657, 27.610).

How does degree revalidation (Reválida) differ from ministerial convalidation (Convalidación) in Argentina?

Convalidación is a direct administrative recognition process managed by the Argentine Ministry of Education (Ministerio de Capital Humano / Dirección Nacional de Gestión Universitaria) for medical graduates from countries with bilateral or multilateral educational reciprocity treaties (such as Bolivia, Chile, Colombia, Cuba, Ecuador, Peru, Spain). Reválida is the university-based academic revalidation pathway conducted by national universities (such as UBA) for graduates from all other countries or when direct convalidation requirements are not met.

What Argentine medical legislation is essential to study for the exam?

High-yield statutory legislation includes: Ley 17.132 (Legal framework for medical practice and prohibitions), Ley 26.529 (Patient Rights, Informed Consent, and Medical Record ownership/custody), Ley 26.657 (National Mental Health Act and involuntary admission criteria), Ley 27.610 (Access to Voluntary and Legal Interruption of Pregnancy - IVE/ILE), Ley 15.465 (Mandatory Communicable Disease Notification), and DEIS death certification regulations.

What specific regional infectious diseases in Argentina are tested?

Candidates must master the epidemiology, diagnosis, and treatment of endemic Argentine infectious diseases: Chagas disease (Trypanosoma cruzi: acute vs chronic indeterminate vs cardiac/digestive forms, RBBB+LAFB ECG, benznidazole/nifurtimox), Dengue virus (Aedes aegypti: critical phase, warning signs, fluid resuscitation), Hantavirus pulmonary syndrome (Andes virus transmitted by Oligoryzomys longicaudatus, atypical immunoblasts, person-to-person transmission), and Tuberculosis (Argentine National Tuberculosis Control Program 2HRZE/4HR regimen).

Can I use foreign clinical guidelines (e.g., US/European) during the exam?

While foundational international medicine concepts (e.g., ATLS, KDIGO, GINA, GOLD, AHA/ESC) are universally applicable, questions on immunization, communicable diseases, obstetrical screening, diabetes diagnosis, and forensic/legal medicine are strictly graded against Argentine National Consensus Guidelines (Sociedad Argentina de Pediatría, Sociedad Argentina de Cardiología, Sociedad Argentina de Diabetes) and Argentine statutory laws.

What happens after passing the UBA Reválida examination?

After successfully passing the written examination (and any required practical or specialty deficiency evaluations determined by the UBA evaluation committee), the UBA Consejo Directivo approves the revalidation resolution. Candidates are issued an official Argentine medical degree certificate (Diploma de Reválida), allowing them to register with the Argentine Ministry of Health to obtain their National Medical License (Matrícula Nacional) and register for the Examen Único de Residencias Médicas.

Is the UBA reválida exam taken in English?

No. The Examen General de Competencia Profesional is taken in Spanish at the Facultad de Medicina, and applicants from non-Spanish-speaking countries must also pass a Spanish-language test plus prior checks in Argentine History, Geography and Civics. This bank is an English-language multiple-choice study adaptation of the published prevalent topics (Medicina Interna, Cirugía, Pediatría, Tocoginecología, Salud Mental/Psiquiatría, Medicina Legal y Deontología Médica and Salud Pública); it is a study aid, not an official translation or a simulation of the real sitting.